These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31081060)

  • 1. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways.
    Meng L; Ji R; Dong X; Xu X; Xin Y; Jiang X
    Int J Oncol; 2019 Jun; 54(6):2069-2079. PubMed ID: 31081060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg3-induced EGFR/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4/LeY expression.
    Shan X; Aziz F; Tian LL; Wang XQ; Yan Q; Liu JW
    Int J Oncol; 2015 Apr; 46(4):1667-76. PubMed ID: 25672851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation.
    Shan X; Fu YS; Aziz F; Wang XQ; Yan Q; Liu JW
    PLoS One; 2014; 9(12):e115401. PubMed ID: 25521755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-κB/p65 signaling pathway to promote melanoma cell death.
    Shan X; Tian LL; Zhang YM; Wang XQ; Yan Q; Liu JW
    Int J Oncol; 2015 Aug; 47(2):701-9. PubMed ID: 26094873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
    Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
    Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
    Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
    Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
    Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
    Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
    Lu M; Fei Z; Zhang G
    Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.
    Guo JQ; Zheng QH; Chen H; Chen L; Xu JB; Chen MY; Lu D; Wang ZH; Tong HF; Lin S
    Int J Oncol; 2014 Sep; 45(3):1065-72. PubMed ID: 24938458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1.
    Li J; Qi Y
    Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rg3 Inhibition of Thyroid Cancer Metastasis Is Associated with Alternation of Actin Skeleton.
    Wu W; Zhou Q; Zhao W; Gong Y; Su A; Liu F; Liu Y; Li Z; Zhu J
    J Med Food; 2018 Sep; 21(9):849-857. PubMed ID: 30136914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
    Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
    Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
    Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ
    Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells.
    Chen J; Peng H; Ou-Yang X; He X
    Melanoma Res; 2008 Oct; 18(5):322-9. PubMed ID: 18781130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways.
    Tang M; Bian W; Cheng L; Zhang L; Jin R; Wang W; Zhang Y
    Int J Mol Med; 2018 Mar; 41(3):1487-1499. PubMed ID: 29328420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
    Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
    PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of HDAC3 by ginsenoside Rg3 inhibits epithelial-mesenchymal transition of cutaneous squamous cell carcinoma through c-Jun acetylation.
    Zhang L; Shan X; Chen Q; Xu D; Fan X; Yu M; Yan Q; Liu J
    J Cell Physiol; 2019 Dec; 234(12):22207-22219. PubMed ID: 31192452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng.
    Mochizuki M; Yoo YC; Matsuzawa K; Sato K; Saiki I; Tono-oka S; Samukawa K; Azuma I
    Biol Pharm Bull; 1995 Sep; 18(9):1197-202. PubMed ID: 8845804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Metastasis Effects of Ginsenoside Rg3 in B16F10 Cells.
    Lee SG; Kang YJ; Nam JO
    J Microbiol Biotechnol; 2015 Dec; 25(12):1997-2006. PubMed ID: 26370799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.
    Sun C; Yu Y; Wang L; Wu B; Xia L; Feng F; Ling Z; Wang S
    J Exp Clin Cancer Res; 2016 Feb; 35():32. PubMed ID: 26872471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.